The Core

Bacteria as Biofactories of therapeutic selenium-based nanomaterials

Leveraging on selected bacterial strains from our library

Self-sustained and scalable production

Bacteria is constantly growing in reactors with low maintenance and producing valuable nanomaterials at a fast rate

Valuable biomedical therapeutics

Our nanomaterials can be used in a wide array of biomedical applications (antimicrobial, anticancer, …) with a high degree of versatility

Easy implementation
and deployment

The nanomaterials can be used as sole therapeutics or be easily combined with existing platforms for a fast deployment

Bacterial-Produced selenium nanomaterials

An endless universe of possibilities

Our bacterial-produced selenium nanomaterials redefine the possibilities of nanotechnology as a biomedical tool

Newly engineered biological selenium nanoparticles (BioSeNPs) are a strong candidate for selective antimicrobial agents that can easily target the desired bacterial strains while leaving the rest of the host microbiome unharmed and without triggering a resistance response as seen with other commercially available nanoparticles or traditional antibiotics.

Other applications include anticancer agents, drug/gene delivery vehicle and antioxidant active components, among many others.

Selected Publications

Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus(MRSA), Escherichia coli, and Pseudomonas aeruginosa.

David Medina Cruz et al.

Biological synthesis of metallic nanoparticles.

Rasesh Y. Parikh et al.

Diversity of Bacterial Synthesis of Silver Nanoparticles.

Fazlurrahman Khan et al.

Biomedical Applications

Bacterial-produced selenium nanomaterials can meet the needs in a wide number of therapeutics areas of interest

Antimicrobials

Antifungals

Oncology

Antioxidants

Skin disorders

Diabetes